Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
03/2012
03/20/2012US8137953 Lactic acid-producing yeast cells having nonfunctional L- or D-lactate:ferricytochrome C oxidoreductase cells
03/20/2012US8137952 Thermostable lactobacillus strains
03/20/2012US8137951 Methods for producing hyaluronan in a recombinant host cell
03/20/2012US8137950 Bacteriophage resistant lactic acid bacteria
03/20/2012US8137949 Biosynthesis of commodity chemicals
03/20/2012US8137941 Chondroitin polymerase and DNA encoding the same
03/20/2012US8137940 Method for production of biomass using a gluconobacter oxydans comprising an inactivated NADP dependent glucose dehydrogenase gene
03/20/2012US8137928 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms
03/20/2012US8137911 Using promoter sequences and RNA polymerase to generate nucleotide sequences corresponding to target gene sequences; gene expression inhibition and diagnostic probe generation
03/20/2012US8137706 Nutrient broth comprising glucomannan hydrolysates for use in promoting gastrointestinal health
03/20/2012US8137408 Autologous bone graft material
03/20/2012CA2752403A1 Syrup and sugar prepared from maple sap or maple syrup and process for preparation thereof
03/20/2012CA2505869C Live attenuated vaccine against porcine pleuropneumonia
03/20/2012CA2472477C Methods and compositions for protein expression and purification
03/20/2012CA2464268C Regulated nucleic acid expression system
03/20/2012CA2435683C Hybridoma cell line g250 and its use for producing monoclonal antibodies
03/20/2012CA2429172C Novel mutant allergens
03/20/2012CA2426793C Bacillus thuringiensis proteins and variants thereof with pesticidal activity against coleopterans
03/20/2012CA2379564C Structural protein of adeno-associated virus with modified chromatographic properties, its production and use
03/20/2012CA2355947C Subtilase enzymes of the i-s1 and i-s2 sub-groups having an additional amino acid residue in an active site loop region
03/20/2012CA2313445C Expression cloning in filamentous fungi
03/20/2012CA2299560C Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications
03/20/2012CA2229328C Genetically engineered yeast strains
03/15/2012WO2012034077A2 Compositions and methods related to attenuated staphylococcal strains
03/15/2012WO2012034023A2 Recombinant clostridia that fix co2 and co and uses thereof
03/15/2012WO2012033832A2 Integration of a polynucleotide encoding a polypeptide that catalyzes pyruvate to acetolactate conversion
03/15/2012WO2012033714A2 Cells for chromatin immunoprecipitation and methods for making
03/15/2012WO2012033359A2 Method of preparing alkyl butyrate from fermented liquid using microorganisms
03/15/2012WO2012033334A2 Recombinant microorganism having an improved ability to produce butanol and a production method for butanol using the same
03/15/2012WO2012033181A1 Culture method and culture device
03/15/2012WO2012033151A1 Composition for preventing inflammations
03/15/2012WO2012033112A1 Coryneform bacterium transformant and method for producing phenol using same
03/15/2012WO2012032853A1 Method for preparation of algal cells, and kit for evaluation of toxicity of chemical substance
03/15/2012WO2012032763A1 Vangl1 peptides and vaccines including the same
03/15/2012WO2012032498A2 Developments in meningococcal outer membrane vesicles
03/15/2012WO2012031851A1 Lactococcus lactis strain with high vitamin k2 production
03/15/2012WO2012031421A1 Gene of cotton epsp synthetase variant and uses thereof
03/15/2012WO2012006342A3 Ceramide-like glycolipid-associated bacterial vaccines and uses thereof
03/15/2012WO2011137401A3 Redirected bioenergetics in recombinant cellulolytic clostridium microorganisms
03/15/2012WO2011116042A3 Processes using antibiotic alternatives in bioethanol production
03/15/2012WO2011106491A3 Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom
03/15/2012WO2011085071A3 Attenuated francisella mutants and methods of use
03/15/2012WO2010138786A8 Bioremediation method
03/15/2012WO2003041560A3 Compounds and methods for treatment and diagnosis of chlamydial infection
03/15/2012US20120066793 Methods and compositions for controlling plant pests
03/15/2012US20120066781 Phytases, nucleic acids encoding them and methods for making and using them
03/15/2012US20120065380 Dual targeting antibody of novel form, and use thereof
03/15/2012US20120065251 Mir-21 promoter driven targeted cancer therapy
03/15/2012US20120065136 Recombinant factor viii having enhanced stability following mutation at the a1-c2 domain interface
03/15/2012US20120065106 Methods and Compositions for Enhanced Protein Expression and Purification
03/15/2012US20120064630 Eukaryotic host cell comprising an expression enhancer
03/15/2012US20120064629 Variant isoprenoid producing enzymes and uses thereof
03/15/2012US20120064622 Methods and Systems for Chemoautotrophic Production of Organic Compounds
03/15/2012US20120064621 Cell Culture Compositions Capable of Producing a VEGF-Binding Fusion Polypeptide
03/15/2012US20120064608 Method of culturing photosynthetic organisms
03/15/2012US20120064607 Fermentation on pentose sugars
03/15/2012US20120064606 Method for producing high concentrate lactic acid bacteria with membrane bioreactor and freeze-dried, lactic acid bacteria powder
03/15/2012US20120064605 Anaerobic Microbial Composition and Methods of Using Same
03/15/2012US20120064603 Selective access to cryopreserved samples
03/15/2012US20120064598 Mutation of the parkin gene, compositions, methods and uses
03/15/2012US20120064592 Biocatalysts synthesizing deregulated cellulases
03/15/2012US20120064591 Recombinant yeast with improved ethanol tolerance and related methods of use
03/15/2012US20120064587 Recombinant clostridia that fix co2 and co and uses thereof
03/15/2012US20120064586 Multimeric Oxidoreductases
03/15/2012US20120064585 Increased Heterologous Fe-S Enzyme Activity in Yeast
03/15/2012US20120064582 Nucleotide Sequences Encoding Alanine Racemase from Coryneform
03/15/2012US20120064581 Escherichia coli metabolic engineering oxygen independent platform strains and methods of use thereof
03/15/2012US20120064572 Bacterial Virulence Factors And Uses Thereof
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064570 Novel cell penetrating peptide
03/15/2012US20120064568 Endomannosidases in the modification of glycoproteins in eukaryotes
03/15/2012US20120064561 Activity of fe-s cluster requiring proteins
03/15/2012US20120064560 Folding of recombinant proteins via co-expression of archaeal chaperones
03/15/2012US20120064548 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064541 N-glycan core beta-galactosyltransferase and uses thereof
03/15/2012US20120064508 Operation and Control of V-Trough Photobioreactor Systems
03/15/2012US20120064120 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064119 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064115 Recombinant virus-like particles encoded by multi-gene vector
03/15/2012US20120064114 Use of e. coli surface antigen 3 sequences for the export of heterologous antigens
03/15/2012US20120064106 Flagellin fusion proteins and use thereof to induce immune responses against pseudomonas aeruginosa
03/15/2012US20120064093 Antibody
03/15/2012US20120064084 Signal transduction protein tab2
03/15/2012US20120064077 Stable and soluble antibodies inhibiting tnf alpha
03/15/2012US20120064074 Antigen binding domains
03/15/2012US20120064064 Antigen-binding proteins
03/15/2012US20120064001 Anti-VEGF Antibody Compositions and Methods
03/15/2012US20120063998 Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody
03/15/2012US20120063995 Non-ad5 adenoviral vectors and methods and uses related thereto
03/15/2012CA2810971A1 Developments in meningococcal outer membrane vesicles
03/15/2012CA2810698A1 Composition for preventing inflammations
03/15/2012CA2810420A1 Xylanases active during pretreatment of cellulosic biomass
03/15/2012CA2810244A1 Integration of a polynucleotide encoding a polypeptide that catalyzes pyruvate to acetolactate conversion
03/14/2012EP2428800A1 Pharmaceutical compositions and methods to vaccinate against mucosal candidiasis
03/14/2012EP2428581A1 Method for identifying at least two groups of microorganisms
03/14/2012EP2428573A2 Improved production of bacterial strains cross reference to related applications
03/14/2012EP2427566A1 Probiotic microorganisms isolated from donkey milk
03/14/2012EP2427562A2 Continuous culture for 1,3-propanediol production using high glycerine concentration
03/14/2012EP2427559A2 Biotransformation using genetically modified candida
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 1489